The Latest

Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital

When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.

By Sony Salzman

From Incarceration to Post-Release, Local Programs Improve Inmate Care for HIV and Hepatitis C

Two models, one from Washington State and another from Los Angeles County, can be duplicated elsewhere to get people into care, experts say.

By Stephen Hicks

Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C

"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.

By Sean R. Hosein for Canadian AIDS Treatment Information Exchange

New State-Level Maps from HepVu Show Impact of Hepatitis C Epidemic Across the U.S.

The data also reveals an estimated 2.3 million people living with HCV infection in the U.S. between 2013 and 2016, with a high burden in the West and in some Appalachian states.

By Corinna Dan, R.N., M.P.H. for U.S. Department of Health and Human Services

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

By Barbara Jungwirth and Myles Helfand

Hepatitis C Treatment Slashes Risk of Cancer and Improves Life Expectancy, Study Finds

Prior studies have indicated that hepatitis C direct-acting antivirals reduce the risk of hepatocellular carcinoma, but this is the first large prospective study to compare outcomes among treated and untreated patients.

By Sony Salzman

This Week in HIV Research: Rethinking PrEP Guidelines

Alternate PrEP guideline recommendations; partner notification and onward HIV transmission; shifting causes of death among HIV/HCV-coinfected people; correlates of lower adherence among people on methadone maintenance.

By Barbara Jungwirth and Myles Helfand

New Professional Resources for Providers to Address HIV/HCV Coinfection

Several new HIV/HCV coinfection resources for the HIV workforce were recently released by partners of the U.S. Department of Health and Human Services. Here's the department's quick roundup.

By Corinna Dan, R.N., M.P.H. for U.S. Department of Health and Human Services

This Week in HIV Research: Check Your Frailty

The link between frailty and chronic disease development; Atripla’s long-term efficacy; the dangers of restrictive eligibility criteria for hepatitis C treatment; nicotine metabolism rates in people living with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Do We Need New Statin Guidelines?

Cholesterol guidelines may underestimate statin value; shifting from Ryan White CARE Act to Affordable Care Act coverage; HCV seroconversion and CD4 count suppression; HCV reinfection odds by risk group.

By Barbara Jungwirth and Myles Helfand